Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: A randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
- Y. M. Chen
- , R. P. Perng
- , Y. C. Lee
- , J. F. Shih
- , C. S. Lee
- , C. M. Tsai
- , J. Whang-Peng
- National Yang Ming Chiao Tung University
- National Cheng Kung University
- Veterans General Hospital-Taipei
Research output: Contribution to journal › Article › peer-review
55
Citations
(Scopus)